Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Potent plasmablast-derived antibodies elicited by the national institutes of health dengue vaccine

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Magnani, D. M.
  • Silveira, C. G. T.
  • Ricciardi, M. J.
  • Gonzalez-Nieto, L.
  • Pedreno-Lopez, N.
  • Bailey, V. K.
  • Gutman, M. J.
  • Maxwell, H. S.
  • Domingues, A.
  • Costa, P. R.
  • Ferrari, L.
  • Goulart, R.
  • Martins, M. A.
  • Martinez-Navio, J. M.
  • Fuchs, S. P.
  • Kalil, J.
  • Timenetsky, M. D.
  • Wrammert, J.
  • Whitehead, S. S.
  • Burton, Dennis
  • Desrosiers, R. C.
  • Kallas, E. G.
  • Watkins, D. I.

publication date

  • November 2017

journal

  • Journal of Virology  Journal

subject areas

  • Adult
  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Dengue Vaccines
  • Dengue Virus
  • Female
  • HEK293 Cells
  • Humans
  • Male
  • National Institutes of Health (U.S.)
  • Plasma Cells
  • United States
scroll to property group menus

Research

keywords

  • B cell
  • Butantan-DV
  • TV003
  • dengue
  • monoclonal antibodies
  • plasmablast
  • vaccines
scroll to property group menus

Identity

PubMed Central ID

  • PMC5660501

International Standard Serial Number (ISSN)

  • 0022-538X

Digital Object Identifier (DOI)

  • 10.1128/jvi.00867-17

PubMed ID

  • 28878078
scroll to property group menus

Additional Document Info

start page

  • e00867

end page

  • 17

volume

  • 91

issue

  • 22

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support